A股異動 | 隆基股份漲5% 第三季淨利同比增14.39% 隆基HJT電池效率達26.3%
格隆匯10月29日丨隆基股份午後快速拉昇,現漲6.59%,報95元,總市值5142億元。隆基股份28日披露三季報,公司2021年第三季度實現營業收入211.07億元,同比增長54.17%,前三季度同比增66.13%;第三季度淨利潤25.63億元,同比增長14.39%,環比增3%,前三季度同比增18.87%。同日,公司宣佈,經世界公認權威測試機構測試,隆基硅基異質結電池(HJT)再次取得重大突破,轉換效率高達26.3%。這是繼上週首次在M6全尺寸單晶硅片上實現光電轉換效率達25.82%後,隆基創造的又一項新的世界紀錄,也是目前為止,全球晶硅FBC結構電池的最高效率。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.